Methods and compositions for producing novel conjugates of throm

Details Methods and compositions for producing novel conjugates of throm Methods and compositions for producing novel conjugates of throm

1996-07-01

1998-11-24

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514314, 546153, 546166, 546172, A61K 31415, C07D40106

Patent

active

058407332

ABSTRACT:
Novel compounds comprising chemically reactive intermediates which can react with available reactive functionalities on blood components to form covalent linkages, where the resulting covalently-bound conjugates are found to have thrombin inhibition activity are provided. Specifically, the thrombin inhibitor compounds of the present invention are derivatives of the known thrombin inhibitor argatroban, which can be covalently linked to chemically reactive functionalities on various blood components. The conjugated thrombin inhibitors thereby have extended lifetimes in the bloodstream, as compared to the unconjugated parent drug, and are, therefore, capable of maintaining thrombin inhibitory activity for extended periods of time as compared to the unconjugated parent drug. Also provided herein are methods for inhibiting thrombin activity in vivo comprising administering to the bloodstream of a mammalian host the novel compounds of the present invention.

REFERENCES:
patent: 3622615 (1971-11-01), Nicolaides et al.
patent: 3978045 (1976-08-01), Okamoto et al.
patent: 4066773 (1978-01-01), Okamato et al.
patent: 4069329 (1978-01-01), Okamato et al.
patent: 4117127 (1978-09-01), Okamato et al.
patent: 4131673 (1978-12-01), Okamato et al.
patent: 4258192 (1981-03-01), Okamoto et al.
Kumon, K., et al., "Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation," Critical Care Medicine, 12(12):1039-1104 (1984).
Ota, K., et al., "Clinical Evaluation of a New Thrombin Inhibitor Available for Haemodialysis," Proc. EDTA, 20:144-149 (1983).
Kikumoto, R., et al., "Selective Inhibition of Thrombin by idinecarboxylic Acid," Biochemistry, 23:85-90 (1984).
Kumada, T. And Y. Abiko, "Comparative Study on Heparin and A Synthetic Thrombin Inhibitor No. 805 (MD-805*) In Experimental Antithrombin III-Deficient Animals," Thrombosis Research, 24:285-298 (1981).
Okamoto, S., et al, "Potent Inhibition of Thrombin by the Newly Synthesized Arginine Derivative No. 805. The Importance of Stereostructure of its Hydrophobic Carboxamide Portion," Biochemical and Biophysical Research Communication, 101(2):440-446 (1981).
"804. Argatroban," The Merck Index: an Encyclopedia of Chemicals, Drigs, and Biologicals. 11th Edition, (eds. Budavan, S., et al.) Merck Induex & Co., Rahway: New Jersey (1989).

Affiliated with

Also associated with

Rating

Methods and compositions for producing novel conjugates of throm does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for producing novel conjugates of throm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for producing novel conjugates of throm will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1702545